Breaking News Instant updates and real-time market news.

CRSP

CRISPR Therapeutics

$21.24

0.49 (2.36%)

16:40
03/20/17
03/20
16:40
03/20/17
16:40

CRISPR Therapeutics says CFO Becker to go on family leave

CRISPR Therapeutics disclosed in a regulatory filing that effective March 21, Marc Becker, Senior Vice President and CFO of CRISPR Therapeutics, who has served as the company's CFO since February 2016, will go on a family and medical leave of absence. The company currently plans to provide an update on the status of Mr. Becker's leave of absence prior to the end of the second quarter. During Mr. Becker's leave of absence and effective March 21, Samarth Kulkarni, Ph.D., the company's Chief Business Officer will serve as the company's acting principal financial officer and Michael Esposito, the Company's Senior Director, Controller, will serve as the company's acting principal accounting officer.

CRSP CRISPR Therapeutics
$21.24

0.49 (2.36%)

02/16/17
PIPR
02/16/17
NO CHANGE
Target $21
PIPR
Overweight
Piper's Schimmer calls CRISPR selloff 'major overreaction'
Piper Jaffray analyst Joshua Schimmer views yesterday's selloff in shares of CRISPR Therapeutics (CRSP) as a "major overreaction." The stock closed yesterday down 8%, or $1.36, to $15.90 after the patent office did not allow the patent interference with UC Berkeley versus Broad Institute over a Crispr/Cas-9 patent. Now that it's deemed patentable, CRISPR will move forward to get its own claims issued and likely move towards a second interference, Schimmer tells investors in a research note. CRISPER and Intellia Therapeutics (NTLA) are essentially litigation partners against the Broad, and now have the chance to win by knocking out Editas Medicine's (EDIT) single-guide tracr patent or by showing it was the first to invent and reduce to practice the application in eukaryotes, the analyst contends. Schimmer says he can't understand why Editas' valuation is higher than CRISPR's. He believes it should be the opposite. The analyst keeps an Overweight rating on CRISPR with a $21 price target.
02/15/17
JEFF
02/15/17
NO CHANGE
JEFF
Patent ruling best case for Editas Medicine, says Jefferies
Jefferies analyst Gena Wang views the United States Patent and Trademark Office's judgment of "no interference-in-fact" for the CRISPR/Cas9 interference motion phase as the "best case" for Editas Medicine (EDIT), Broad Institute's licensee. The analyst sees three choices for The University of California, which has CRISPR Therapeutics (CRSP) and Intellia Therapeutics (NTLA) as licensees: Appeal, seek second interference, or discuss a settlement. Wang sees cross-licensing as the likely eventual path taken by both parties. CRISPR and Intellia could license from Editas the use of CRISPR in eukaryotic cells, while Editas could license from the two companies the use of single guide and tracrRNA, the analyst tells investors in a research note. She believes a royalty could be in the mid-single-digit range. Shares of Editas are up 33% to $24.99 in afternoon while CRISPR is down 13% to $15.05 and Intellia is down 11% to $12.26.
11/15/16
SBSH
11/15/16
INITIATION
Target $19
SBSH
Neutral
CRISPR Therapeutics initiated with a Neutral at Citi
Citi analyst Yigal Nochomovitz started CRISPR Therapeutics with a Neutral rating and $19 price target. The risk/reward is balanced with the stock up 25% since the initial public offering, Nochomovitz tells investors in a research note. The analyst sees "no clear winner" in the gene editing patent debate.
11/14/16
11/14/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Conagra Brands (CAG) initiated with a Neutral at UBS. 2. CRISPR Therapeutics (CRSP) initiated with an Overweight at Barclays, an Overweight at Piper Jaffray, and a Buy at Guggenheim. 3. Forterra (FRTA) initiated with a Neutral at Goldman, an Outperform at RBC Capital, a Buy at Citi, an Outperform at Oppenheimer, a Hold at Deutsche Bank, and a Buy at SunTrust. 4. iRhythm Technologies (IRTC) initiated with an Overweight at JPMorgan, a Buy at BTIG, a Buy at Canaccord, and an Overweight at Morgan Stanley. 5. Teva (TEVA) reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

18:01
05/25/17
05/25
18:01
05/25/17
18:01
General news
DOJ to seek review of Trump travel ban in Supreme Court »

Attorney General Jeff…

SITE

SiteOne Landscape

$51.93

1.59 (3.16%)

17:46
05/25/17
05/25
17:46
05/25/17
17:46
Hot Stocks
SiteOne Landscape acquires Evergreen Partners »

SiteOne Landscape Supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$282.06

2.01 (0.72%)

17:45
05/25/17
05/25
17:45
05/25/17
17:45
Hot Stocks
Lockheed Martin LM-100J makes successful first flight »

The first Lockheed Martin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

17:45
05/25/17
05/25
17:45
05/25/17
17:45
General news
Breaking General news story  »

Dallas Federal Reserve…

LGF.A

Lionsgate

$25.55

0.4 (1.59%)

, LGF.B

Lionsgate

$23.45

0.31 (1.34%)

17:43
05/25/17
05/25
17:43
05/25/17
17:43
Hot Stocks
Lionsgate sees low to mid teens adjusted OIBDA growth, warns of near-term spend »

"We're…

LGF.A

Lionsgate

$25.55

0.4 (1.59%)

LGF.B

Lionsgate

$23.45

0.31 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 27

    Jun

DXC

DXC Technology

$78.64

0.69 (0.89%)

17:41
05/25/17
05/25
17:41
05/25/17
17:41
Earnings
DXC Technology sees FY18 adjusted EPS $6.50-$7.00, consensus $6.72 »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

GME

GameStop

$23.62

0.91 (4.01%)

, NTDOY

Nintendo

$35.95

0.4 (1.13%)

17:36
05/25/17
05/25
17:36
05/25/17
17:36
Hot Stocks
GameStop sees 'strong' Switch demand outpacing supply in near term »

GameStop (GME) sees…

GME

GameStop

$23.62

0.91 (4.01%)

NTDOY

Nintendo

$35.95

0.4 (1.13%)

TWX

Time Warner

$99.37

0.97 (0.99%)

T

AT&T

$38.23

0.08 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 31

    May

  • 31

    May

  • 15

    Jun

NTNX

Nutanix

$17.57

0.12 (0.69%)

, DECK

Deckers Brands

$56.57

-1.51 (-2.60%)

17:36
05/25/17
05/25
17:36
05/25/17
17:36
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

NTNX

Nutanix

$17.57

0.12 (0.69%)

DECK

Deckers Brands

$56.57

-1.51 (-2.60%)

ULTA

Ulta Beauty

$293.04

12.53 (4.47%)

EGHT

8x8, Inc.

$13.15

0.05 (0.38%)

VEEV

Veeva

$61.74

0.67 (1.10%)

COST

Costco

$174.73

1.72 (0.99%)

BIG

Big Lots

$48.37

1.39 (2.96%)

TGNA

Tegna

$23.71

0.26 (1.11%)

NXST

Nexstar

$57.50

-1.3 (-2.21%)

ZOES

Zoe's Kitchen

$16.20

-0.18 (-1.10%)

GME

GameStop

$23.62

0.91 (4.01%)

SPLK

Splunk

$67.09

0.92 (1.39%)

MRVL

Marvell

$16.94

0.16 (0.95%)

TRIL

Trillium Therapeutics

$5.45

-0.15 (-2.68%)

TRGP

Targa Resources

$48.47

-1.11 (-2.24%)

AERI

Aerie Pharmaceuticals

$54.25

13.75 (33.95%)

MACK

Merrimack

$3.40

-0.04 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 26

    May

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 08

    Jun

  • 08

    Jun

  • 13

    Jun

  • 15

    Jun

  • 20

    Jun

  • 28

    Jun

  • 29

    Jun

  • 14

    Jul

  • 28

    Feb

  • 26

    May

OKE

ONEOK

$51.66

-1.12 (-2.12%)

, OKS

ONEOK Partners

$50.70

-1.04 (-2.01%)

17:34
05/25/17
05/25
17:34
05/25/17
17:34
Hot Stocks
ONEOK names Walter Hulse III CFO »

ONEOK (OKE) and ONEOK…

OKE

ONEOK

$51.66

-1.12 (-2.12%)

OKS

ONEOK Partners

$50.70

-1.04 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$34.34

0.07 (0.20%)

17:32
05/25/17
05/25
17:32
05/25/17
17:32
Hot Stocks
AstraZeneca recalls one lot of Brilinta sample bottles »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NTNX

Nutanix

$17.57

0.12 (0.69%)

17:29
05/25/17
05/25
17:29
05/25/17
17:29
Technical Analysis
Technical View: Nutanix breaks out, rounding pattern in progress »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 08

    Jun

BIG

Big Lots

$48.37

1.39 (2.96%)

, COST

Costco

$174.73

1.72 (0.99%)

17:27
05/25/17
05/25
17:27
05/25/17
17:27
Hot Stocks
Breaking Hot Stocks news story on Big Lots, Costco »

Big Lots up 3.4% after…

BIG

Big Lots

$48.37

1.39 (2.96%)

COST

Costco

$174.73

1.72 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 26

    May

  • 31

    May

WING

Wingstop

$29.72

-0.12 (-0.40%)

17:19
05/25/17
05/25
17:19
05/25/17
17:19
Hot Stocks
Wingstop CFO Mravle to resign effective June 23, 2017 »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HUBG

Hub Group

$34.10

-0.05 (-0.15%)

17:17
05/25/17
05/25
17:17
05/25/17
17:17
Hot Stocks
Hub Group acquires Estenson Logistics »

Hub Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$23.62

0.91 (4.01%)

, NTDOY

Nintendo

$35.95

0.4 (1.13%)

17:14
05/25/17
05/25
17:14
05/25/17
17:14
Hot Stocks
GameStop: Red Dead 2 delay, Switch demand keep company at initial FY17 guidance »

GameStop (GME) says Q2…

GME

GameStop

$23.62

0.91 (4.01%)

NTDOY

Nintendo

$35.95

0.4 (1.13%)

TTWO

Take-Two

$78.53

0.8 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 31

    May

RELL

Richardson Electronics

$5.96

-0.04 (-0.67%)

17:09
05/25/17
05/25
17:09
05/25/17
17:09
Hot Stocks
Richardson Electronics sells PACS display businss to Double Black Imaging »

Richardson Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$23.62

0.91 (4.01%)

, NTDOY

Nintendo

$35.95

0.4 (1.13%)

17:09
05/25/17
05/25
17:09
05/25/17
17:09
Hot Stocks
GameStop backs FY17 new hardware sales view to unchanged to up slightly »

GameStop (GME) says it…

GME

GameStop

$23.62

0.91 (4.01%)

NTDOY

Nintendo

$35.95

0.4 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 31

    May

COST

Costco

$174.73

1.72 (0.99%)

17:07
05/25/17
05/25
17:07
05/25/17
17:07
Hot Stocks
Costco reports Q3 comparable sales up 5% »

Reports Q3 comparable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$41.00

0.76 (1.89%)

17:04
05/25/17
05/25
17:04
05/25/17
17:04
Hot Stocks
Mallinckrodt reports on study of Acthar Gel after multiple sclerosis relapse »

Mallinckrodt highlights…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

FRGI

Fiesta Restaurant

17:03
05/25/17
05/25
17:03
05/25/17
17:03
Hot Stocks
Fiesta Restaurant rejects 'misleading' claims by activist group JCP »

Fiesta Restaurant Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$72.13

0.18 (0.25%)

17:02
05/25/17
05/25
17:02
05/25/17
17:02
Hot Stocks
Taco Bell to add restaurants domestically to reach $15B sales goal »

Taco Bell, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

LBIO

Lion Biotechnologies

$6.15

-0.35 (-5.38%)

16:57
05/25/17
05/25
16:57
05/25/17
16:57
Hot Stocks
Lion Biotechnologies announces resignation of CFO Gregory Schiffman »

Lion Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CPE

Callon Petroleum

$12.01

-0.08 (-0.66%)

16:55
05/25/17
05/25
16:55
05/25/17
16:55
Hot Stocks
Callon Petroleum names Joseph Gatto, Jr. CEO »

Callon Petroleum Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HGV

Hilton Grand Vacations

$36.32

0.24 (0.67%)

16:54
05/25/17
05/25
16:54
05/25/17
16:54
Syndicate
Breaking Syndicate news story on Hilton Grand Vacations »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYPR

Sypris Solutions

$1.48

0.05 (3.50%)

16:51
05/25/17
05/25
16:51
05/25/17
16:51
Hot Stocks
Sypris Electronics achieves ISO 13485 registration from NSF-ISR »

Sypris Electronics, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.